Botanisol Analytics Inc.

Botanisol Analytics has developed autonomous, portable molecular detection instrumentation designed for rapid disease screening and chemical analysis. Based in Phoenix, Arizona, the company utilizes proprietary Raman spectrometer technology that directs laser light at specimens to measure reflected light, allowing for the detection of pathogens, contaminants, and other molecular markers. By moving away from traditional, laboratory-dependent diagnostic processes, the company aims to provide automated, real-time results in approximately five minutes, using systems that are designed to operate in diverse environments ranging from clinical settings to high-traffic areas like airports and events. The technology is modular and software-updatable, created with the goal of functioning with the convenience of a kiosk while maintaining laboratory-grade accuracy.

The company’s solutions are intended to improve medical triage and enhance biological threat detection for both public health and national security applications. By providing instant, non-invasive screening, Botanisol Analytics seeks to address critical bottlenecks in existing testing supply chains, offering a tool that can be used without highly specialized personnel. Their research and development efforts have been significantly supported by the U.S. Department of the Air Force and involve collaborations with academic medical centers to validate their systems. While their screening tools are designed to identify infection risks and chemical compositions, they are intended for screening rather than final diagnostic purposes and are subject to regulatory review processes for various commercial and healthcare applications.